Fresenius SE & Co KGaA

DE

FREG

Health Care

7.4 ₽

Current price

Hold
7.4 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    139 / 302

  • Position in country

    459 / 963

  • Net income margin, %

    -3.9

    0.6

  • EBITDA margin, %

    22.6

    8.9

  • P/BV

    2.5

    1.2

  • EV/EBITDA

    8.4

    6.9

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    449.3

    45.6

  • Dividend Yield, %

    3.6

    2.6

  • Forward Dividend Yield, %

    15.4

    0.4

  • Expected dividend per share

    1

    0

  • Payout Ratio, %

    0

    18.7

  • Dividend Ex Date

    2023-05-18

Get an analytical review of this company

Competitors

Ranks

  • CorVel Corp

    00%

  • Cigna Group

    00%

  • CVS Health Corp

    00%

  • Fresenius SE & Co KGaA

    00%

  • DaVita Inc

    00%

  • RadNet Inc

    00%

  • Fresenius Medical Care AG

    00%

  • Quest Diagnostics Inc

    00%

  • Laboratory Corporation of America Holdings

    00%

  • Synlab AG

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Germany

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Providers & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    15354

  • Ticker

    FSNUY.PK

  • ISIN

    US35804M1053

  • IPO date

    1986-12-18

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-14

  • Date fact. publication of reports

    2023-12-31

Company Description

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.